Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug？Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)

Kyoungsuk Rhee

Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug？Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)

Kyoungsuk Rhee

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	American Journal of Cardiology
State	Published - 2010.01.15

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{373c2250b5274ec29990e4fa482e2e38,

title = "Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug？Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)",

author = "Kyoungsuk Rhee",

year = "2010",

month = jan,

day = "15",

language = "Korean",

journal = "American Journal of Cardiology",

issn = "0002-9149",

}

TY - JOUR

T1 - Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug？Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)

AU - Rhee, Kyoungsuk

PY - 2010/1/15

Y1 - 2010/1/15

M3 - Journal article

SN - 0002-9149

JO - American Journal of Cardiology

JF - American Journal of Cardiology

ER -